Evidence map›Paper›PMID 22217737›Full record

ReviewThe Journal of investigative dermatology2012

Skin barrier disruption: a requirement for allergen sensitization?

Anna De Benedetto, Akiharu Kubo, Lisa A Beck

Abstract readReview
In one paragraph

Review in The Journal of investigative dermatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed.

  1. Trial
  2. Intradermal grass pollen immunotherapy increases TThe Journal of allergy and clinical immunology · 2017
    Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Novel drug delivery systems in topical treatment of atopic dermatitis.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.JID innovations : skin science from molecules to population health · 2025
    Review
  12. Review
  13. Article
  14. Oral administration ofFrontiers in microbiology · 2025
    Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Review
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna De BenedettoDepartment of Dermatology, University of Rochester Medical Center, Rochester, New York 14642, USA.
Akiharu Kubo
Lisa A Beck

Funding

UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
TRAINING PROGRAM IN DERMATOLOGICAL RESEARCHT32AR007472 · NIAMS · UNIVERSITY OF ROCHESTER · PI PENTLAND, ALICE P · 1987 to 2013
$2.1M
ATOPIC DERMITITIS VACCINIA NETWORK /ADVN/-266040029N01AI040029 · NIAID · NATIONAL JEWISH MEDICAL AND RESEARCH CEN · PI LEUNG, DONALD YM · 2006 to 2006
–
NCRR NIH HHS UL1 RR024160NIAID NIH HHS HHSN272201000017CNIAID NIH HHS HHSN272201000020CNIAID NIH HHS HHSN272201000020INIAID NIH HHS N01 AI040029NIAMS NIH HHS T32 AR007472
6 · The paper itself

Abstract

For at least half a century, noninvasive techniques have been available to quantify skin barrier function, and these have shown that a number of human skin conditions and disorders are associated with defects in skin permeability. In the past decade, several genes responsible for skin barrier defects observed in both monogenetic and complex polygenic disorders have been elucidated and functionally characterized. This has led to an explosion of work in the past 6 years that has identified pathways connecting epidermal barrier disruption and antigen uptake, as well as the quality and/or magnitude of the antigen-specific adaptive immune response. This review will introduce the notion that diseases arise from the dynamic crosstalk that occurs between skin barrier and the immune system using atopic dermatitis or eczema as the disease prototype. Nevertheless, the concepts put forth are highly relevant to a number of antigen-driven disorders for which skin barrier is at least transiently compromised, such as psoriasis, allergic contact dermatitis, and blistering disorders.

Indexed as

AllergensDermatitis, AtopicHumansPermeabilitySkinAllergens

Identifiers

PMID22217737
PMCPMC3279586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.